Activity of a tamoxifen-raloxifene hybrid ligand for estrogen receptors at an AP-1 site

Ross V. Weatherman, David C. Carroll, Thomas S. Scanlan

Research output: Contribution to journalArticle

16 Scopus citations

Abstract

To test the effect of ligand flexibility on the selective transcriptional activities of ERα and ERβ from an AP-1 site, an analogue of raloxifene was made that removed the ketone functionality and made the ligand more planar and conformationally more similar to 4-hydroxytamoxifen. Desketoraloxifene was found to be a much stronger activator at an AP-1 site with ERα than with ERβ, mimicking 4-hydroxytamoxifen more than raloxifene.

Original languageEnglish (US)
Pages (from-to)3129-3131
Number of pages3
JournalBioorganic and Medicinal Chemistry Letters
Volume11
Issue number24
DOIs
StatePublished - Dec 17 2001

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Medicine
  • Molecular Biology
  • Pharmaceutical Science
  • Drug Discovery
  • Clinical Biochemistry
  • Organic Chemistry

Fingerprint Dive into the research topics of 'Activity of a tamoxifen-raloxifene hybrid ligand for estrogen receptors at an AP-1 site'. Together they form a unique fingerprint.

  • Cite this